A Study Of BRL49653C For The Treatment Of Type 2 Diabetes

Clinical trial NCT00523913 · COMPLETED

Trial details

NCT number: NCT00523913
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2005-11-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.